INC Research Holdings Inc
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with… Read more
INC Research Holdings Inc (INCR) - Net Assets
Latest net assets as of June 2025: $432.24 Million USD
Based on the latest financial reports, INC Research Holdings Inc (INCR) has net assets worth $432.24 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($751.76 Million) and total liabilities ($319.52 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $432.24 Million |
| % of Total Assets | 57.5% |
| Annual Growth Rate | N/A |
| 5-Year Change | 36.14% |
| 10-Year Change | 3226.95% |
| Growth Volatility | 533.74 |
INC Research Holdings Inc - Net Assets Trend (2011–2024)
This chart illustrates how INC Research Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INC Research Holdings Inc (2011–2024)
The table below shows the annual net assets of INC Research Holdings Inc from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $397.67 Million | -12.99% |
| 2023-12-31 | $457.06 Million | -12.35% |
| 2022-12-31 | $521.48 Million | +13.56% |
| 2021-12-31 | $459.19 Million | +57.20% |
| 2020-12-31 | $292.11 Million | +14.02% |
| 2019-12-31 | $256.20 Million | +1203.03% |
| 2018-12-31 | $19.66 Million | -4.92% |
| 2017-12-31 | $20.68 Million | -14.08% |
| 2016-12-31 | $24.07 Million | +101.36% |
| 2015-12-31 | $11.95 Million | +1614.89% |
| 2014-12-31 | $697.01K | -82.21% |
| 2013-12-31 | $3.92 Million | -60.17% |
| 2012-12-31 | $9.84 Million | +119.02% |
| 2011-12-31 | $-51.72 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to INC Research Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11056030200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $658.60 Million | 165.91% |
| Other Comprehensive Income | $15.95 Million | 4.02% |
| Total Equity | $396.97 Million | 100.00% |
INC Research Holdings Inc Competitors by Market Cap
The table below lists competitors of INC Research Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
flyExclusive, Inc.
NYSE MKT:FLYX
|
$30.21 Million |
|
Kyung Nong Corporation
KO:002100
|
$30.22 Million |
|
A1 Yenilenebilir Enerji Üretim A.S.
IS:A1YEN
|
$30.22 Million |
|
The LEADCORP Inc
KQ:012700
|
$30.23 Million |
|
RAIZ Invest Ltd
AU:RZI
|
$30.18 Million |
|
Integra Indocabinet Tbk PT
JK:WOOD
|
$30.18 Million |
|
Beforepay Group Ltd
AU:B4P
|
$30.18 Million |
|
Cambuci S.A
SA:CAMB3
|
$30.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INC Research Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 455,112,000 to 396,969,000, a change of -58,143,000 (-12.8%).
- Net loss of 67,795,000 reduced equity.
- New share issuances of 34,000,000 increased equity.
- Other factors decreased equity by 24,348,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-67.80 Million | -17.08% |
| Share Issuances | $34.00 Million | +8.56% |
| Other Changes | $-24.35 Million | -6.13% |
| Total Change | $- | -12.78% |
Book Value vs Market Value Analysis
This analysis compares INC Research Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.09x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | $-176.07 | $0.78 | x |
| 2012-12-31 | $22.52 | $0.78 | x |
| 2013-12-31 | $2.59 | $0.78 | x |
| 2014-12-31 | $0.43 | $0.78 | x |
| 2015-12-31 | $1.35 | $0.78 | x |
| 2016-12-31 | $1.87 | $0.78 | x |
| 2017-12-31 | $1.21 | $0.78 | x |
| 2018-12-31 | $0.95 | $0.78 | x |
| 2019-12-31 | $10.99 | $0.78 | x |
| 2020-12-31 | $10.81 | $0.78 | x |
| 2021-12-31 | $10.97 | $0.78 | x |
| 2022-12-31 | $11.05 | $0.78 | x |
| 2023-12-31 | $9.99 | $0.78 | x |
| 2024-12-31 | $8.31 | $0.78 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently INC Research Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -17.08%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.38%
- • Asset Turnover: 0.31x
- • Equity Multiplier: 1.92x
- Recent ROE (-17.08%) is above the historical average (-29.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | -56.35% | 4.13x | 0.00x | $-1.63 Million |
| 2012 | 441.63% | 512.95% | 0.58x | 1.48x | $42.46 Million |
| 2013 | -168.61% | -80.07% | 1.34x | 1.57x | $-7.00 Million |
| 2014 | -544.18% | -67.13% | 2.14x | 3.79x | $-3.86 Million |
| 2015 | -15.71% | -134.05% | 0.11x | 1.06x | $-3.07 Million |
| 2016 | 1.10% | 0.00% | 0.00x | 1.15x | $-2.14 Million |
| 2017 | -25.43% | 0.00% | 0.00x | 1.16x | $-7.33 Million |
| 2018 | -65.09% | 0.00% | 0.00x | 1.83x | $-14.76 Million |
| 2019 | -2.30% | -66.02% | 0.03x | 1.10x | $-31.49 Million |
| 2020 | -13.56% | -57.25% | 0.20x | 1.19x | $-64.68 Million |
| 2021 | 1.05% | 2.13% | 0.32x | 1.53x | $-40.11 Million |
| 2022 | 8.94% | 11.53% | 0.41x | 1.91x | $-5.31 Million |
| 2023 | -13.61% | -17.43% | 0.45x | 1.73x | $-107.47 Million |
| 2024 | -17.08% | -28.38% | 0.31x | 1.92x | $-107.49 Million |
Industry Comparison
This section compares INC Research Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INC Research Holdings Inc (INCR) | $432.24 Million | 0.00% | 0.74x | $30.19 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |